Ardent Health Investors Face March 9 Deadline in Securities Class Action
The suit centers on claims that Ardent used a 180‑day reserve cliff despite assuring investors of detailed collection reviews.
Overview
- Postiwala v. Ardent Health, Inc., No. 3:26-cv-00022, is pending in the U.S. District Court for the Middle District of Tennessee.
- The putative class period runs from July 18, 2024 through November 12, 2025.
- Plaintiffs also allege inadequate professional malpractice insurance and related disclosure deficiencies.
- Ardent’s November 12, 2025 disclosure cited hindsight evaluations that reduced quarterly revenue by about $43 million and increased professional liability reserves by roughly $54 million.
- The company’s share price fell about 33% to $9.30 on November 13, 2025, and multiple law firms are soliciting investors to seek lead‑plaintiff status by March 9, 2026.